Results 11 to 20 of about 6,820 (243)
Eliminating residual neuromuscular blockade: a literature review. [PDF]
Ann Transl MedAlthough millions of patients receive neuromuscular blocking agents (NMBAs) each year as part of an anesthetic, residual neuromuscular blockade (NMB) remains a too-frequent occurrence and its adverse consequences continue to negatively impact patient outcomes.
Frenkel M, Lien CA.
europepmc +3 more sources
Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade [PDF]
Current Anesthesiology Reports, 2016 Bhananker Sanjay M
exaly +2 more sources
Current recommendations for preventing residual neuromuscular blockade. [PDF]
Anesth Pain Med (Seoul)The use of neuromuscular blocking agents (NMBAs) offers several advantages during surgery under general anesthesia because they help secure the surgical field and facilitate appropriate mechanical ventilation. Eliminating postoperative residual neuromuscular blockade (rNMB) remains a major challenge for anesthesiologists.
Lee JE, Jung H.
europepmc +2 more sources
Residual Neuromuscular Blockade in Critical Care [PDF]
Critical Care Nurse, 2012 Neuromuscular blockade is a pharmacological adjunct for anesthesia and for surgical interventions. Neuromuscular blockers can facilitate ease of instrumentation and reduce complications associated with intubation. An undesirable sequela of these agents is residual neuromuscular blockade.
Jason, Wilson +2 more
openaire +2 more sources
Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade. [PDF]
Biomed Res Int, 2018 Background. Neuromuscular blockade is a risk factor for postoperative respiratory weakness during the immediate postoperative period. The quantitative relationships between postoperative pulmonary-function impairment and residual neuromuscular blockade are unknown.Methods.
Fu S, Lin W, Zhao X, Ge S, Xue Z.
europepmc +4 more sources
Use of neuromuscular blockers in Brazil
Revista Brasileira de Anestesiologia, 2015 The objective of this study was to evaluate how Brazilian anesthesiologists are using neuromuscular blockers, focusing on how they establish the diagnosis of postoperative residual curarization and the incidence of complications associated with the use ...
Giovani de Figueiredo Locks +4 more
doaj +3 more sources
The latest trend in neuromuscular monitoring: return of the electromyography [PDF]
Anesthesia and Pain Medicine, 2021 To reduce the risk of residual neuromuscular blockade, neuromuscular monitoring must be performed. Acceleromyography (AMG)-based neuromuscular monitoring was regarded as “clinical gold standard” and widely applied.
Wonjin Lee
doaj +1 more source
BMC Anesthesiology, 2021 Background Sugammadex reverses neuromuscular blockade induced by steroidal relaxants. We compared the recovery for neuromuscular blockade reversal with sugammadex in children aged 1–12 years. Methods From August 2019 to August 2020, patients who received
Ruidong Zhang +6 more
doaj +1 more source
Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature
Case Reports in Critical Care, 2020 Neuromuscular blocking agents are regularly used in the intensive care unit (ICU) to facilitate mechanical ventilation in patients with acute respiratory distress syndrome and patient-ventilator dyssynchronies.
Jessica D. Workum +2 more
doaj +1 more source
Role of amino acid infusion in delayed recovery from neuromuscular blockers
Indian Journal of Anaesthesia, 2010 This case report highlights the anaesthetic management of a patient who had residual muscle paralysis following neuromuscular blockade, which was attributed to hypothermia and corrected by administration of amino acid solution.
Seema Kalra, Rachna Wadhwa
doaj +1 more source